American Century Companies
PMVP icon

American Century Companies’s PMV Pharmaceuticals PMVP Stock Holding History

American Century Companies’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,241
Closed -$81.4K – 2937
2024
Q2 		$81.4K Buy
50,241
+154
+0.3% +$278 ﹤0.01% 2837
2024
Q1 		$85.1K Buy
50,087
+5,439
+12% +$10.2K ﹤0.01% 2876
2023
Q4 		$138K Buy
44,648
+15,837
+55% +$41.9K ﹤0.01% 2763
2023
Q3 		$177K Buy
28,811
+8,146
+39% +$56K ﹤0.01% 2627
2023
Q2 		$129K Buy
+20,665
New +$108K ﹤0.01% 2629

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American Century Companies's PMVP Position: Q3 2024 in Review

American Century Companies sold out of PMV Pharmaceuticals (PMVP) in Q3 2024, closing a stake of 50,241 shares — an estimated $81.4K sold.

American Century Companies first reported a position in PMVP in Q2 2023 and held it in 5 quarters. The position peaked at $177K in Q3 2023. 74 funds tracked by Wall St. Rank hold PMVP as of Q3 2024.

  • American Century Companies reported no remaining PMV Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • American Century Companies sold 50,241 PMV Pharmaceuticals shares in Q3 2024, an estimated $81.4K.
  • American Century Companies first reported a position in PMV Pharmaceuticals in Q2 2023 and held it in 5 quarters.
  • American Century Companies's PMV Pharmaceuticals position peaked at $177K in Q3 2023.
  • 74 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2024.

Based on American Century Companies's 13F filing for Q3 2024, filed 12 Nov 2024.